Wei Ma
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Natural product bioactivities and synthesis
Papers in
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 7
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- Co-authors
- Zhengwei Yuan (33 shared papers)Xiaowei Wei (32 shared papers)Hui Fang Gu (28 shared papers)Dan Liu (23 shared papers)Kai‐Jin Wang (3 shared papers)Songying Cao (12 shared papers)Guoqing Yan (2 shared papers)Tianchu Huang (10 shared papers)
- Journals
- Cell Death and Disease (4 papers)Journal of Biomedical Materials Research Part B Applied Biomaterials (3 papers)Frontiers in Cell and Developmental Biology (3 papers)Oncology Reports (2 papers)Surface and Coatings Technology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Ma
79 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 248
- Molecular Biology 508
- Biochemistry 39
- Rheumatology 75
- Genetics 51
Countries citing papers authored by Wei Ma
This map shows the geographic impact of Wei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ma more than expected).
Fields of papers citing papers by Wei Ma
This network shows the impact of papers produced by Wei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ma. The network helps show where Wei Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 120 | |
| 2 | 2012 | 74 | |
| 3 | 2015 | 53 | |
| 4 | 2020 | 45 | |
| 5 | 2018 | 39 | |
| 6 | 2017 | 39 | |
| 7 | 2016 | 38 | |
| 8 | 2017 | 34 | |
| 9 | 2021 | 33 | |
| 10 | Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells. | 2004 | 32 |
| 11 | 2018 | 31 | |
| 12 | 2007 | 29 | |
| 13 | 2009 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2022 | 25 | |
| 16 | 2024 | 25 | |
| 17 | 2014 | 24 | |
| 18 | 2019 | 24 | |
| 19 | 2016 | 24 | |
| 20 | 2020 | 24 |
About Wei Ma
Wei Ma is a scholar working on Cancer Research, Molecular Biology, Genetics, Rheumatology and Oral Surgery, having authored 82 papers that have together received 1.3k indexed citations. Recurring topics across this work include Spinal Dysraphism and Malformations (9 papers), MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), Bone Tissue Engineering Materials (6 papers), RNA modifications and cancer (5 papers), Mesenchymal stem cell research (5 papers) and Dental Implant Techniques and Outcomes (5 papers). The work is most often cited by research in Cancer Research (248 citations), Molecular Biology (508 citations), Biochemistry (39 citations), Rheumatology (75 citations) and Genetics (51 citations). Wei Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengwei Yuan, Xiaowei Wei, Hui Fang Gu, Dan Liu, Kai‐Jin Wang, Songying Cao, Guoqing Yan, Tianchu Huang, Yong‐Xian Cheng and Ning Li. Their work appears in journals such as Cell Death and Disease, Journal of Biomedical Materials Research Part B Applied Biomaterials, Frontiers in Cell and Developmental Biology, Oncology Reports and Surface and Coatings Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.